Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDN   US24823Q1076

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on DENDREON CORPORATION
01/27 DENDREON : Regulation FD Disclosure (form 8-K)
01/23 DENDREON : Announces Strong Commercial Start to 2015
01/22 DENDREON : Other Events (form 8-K)
01/22 DENDREON : Results of Operations and Financial Condition, Financial Statements a..
01/22 DENDREON : Cites Strong Commercial Start to 2015
01/21 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
01/19 DENDREON : Cites Strong Commercial Start to 2015
01/15 DENDREON : Announces Strong Commercial Start to 2015
01/12 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON : heads for auction without $275M minimum bidder
2014 DENDREON : Other Events (form 8-K)
2014 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
2014 DENDREON : Entry into a Material Definitive Agreement, Change in Directors or Pr..
2014 DENDREON : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or..
2014 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON CORPORATION : A New Combined Approach to Cancer Immunotherapy is Needed
2014 DENDREON : A New Combined Approach to Cancer Immunotherapy is Needed
2014 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or..
2014 DENDREON : Seattle's Dendreon files for Ch. 11 bankruptcy protection
2014 DENDREON : Chapter 11 Filing story (Clarification)
2014 DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : S&P 500, Dow Hit Intraday Record Highs
2014DJMARKET SNAPSHOT : U.S. Stocks: S&P 500's Record Highs May Be Put To The Test
2014 DENDREON : Drugmaker Dendreon files for Chapter 11 bankruptcy reorganization
2014 DENDREON : files for Ch. 11 bankruptcy protection
2014 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
2014 DENDREON : Entry into a Material Definitive Agreement, Bankruptcy or Receivershi..
2014 DENDREON : Reaches Agreements on Terms of Financial Restructuring
2014 Feature - As music sales fall, sax player Kenny G turns to stockpicking
2014 DENDREON : sinks after drugmaker warns of debt woes
2014 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
2014 Dendreon Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Elects W. Thomas Amick as President and CEO
2014 DENDREON : Taps W. Thomas Amick President
2014 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
2014 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Termination of a Material Definitive Agreement (form 8-K)
2014 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
2014 DENDREON : Announces Leadership Transition
2014 DENDREON : Treatment with PROVENGE® sipuleucel-T Induces Antigen Spread Associat..
2014 DENDREON : Submission of Matters to a Vote of Security Holders (form 8-K)
2014 DENDREON : Announces Presentation of PROVENGE® sipuleucel-T and DN24-02 Immuno-O..
2014 DENDREON : Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associ..
2014 DENDREON : to Present Provenge (sipuleucel-T) and DN24-02 Immuno- Oncology Data ..
2014 DENDREON : Announces First Quarter 2014 Results
2014 DENDREON : Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno..
2014 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
2014 DENDREON : Results of Operations and Financial Condition, Financial Statements a..
2014 DENDREON : Announces First Quarter 2014 Results
2014DENDREON CORPORATION : quaterly earnings release
2014 DENDREON : to Host Conference Call on May 8 to Announce First Quarter Financial ..
2014 DENDREON : Posts Preliminary Data from Analysis of Phase II Stand Study
2014 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® sipuleucel-T i..
2014 DENDREON : Releases Preliminary Data from Analysis of Phase II Stand Study
2014 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
2014 DENDREON : Announces Fourth Quarter and 2013 Year End Results
2014 DENDREON : Announces Plans to Make PROVENGE® Commercially Available in Europe
2014 Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
2014 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
2014 DENDREON CORPORATION : Dendreon Reports Intent to Make Provenge Commercially Ava..
2014 DENDREON CORPORATION : Patent Issued for Promiscuous HER-2/Neu CD4 T Cell Epitop..
2014 DENDREON CORPORATION : Dendreon Corp. Assigned Patent
2014 DENDREON CORPORATION : Dendreon Tests Resistance on Earnings Report, Provenge Ex..
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 Dendreon shares jump on news of prostate drug's European launch
2014 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
2014 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Results of Operation..
2014 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDN | US24823Q1076 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF